Related Experiment Video
Updated: Feb 14, 2026

A Method for Tracking the Time Evolution of Steady-State Evoked Potentials
Published on: May 25, 2019
From concept to application: Exploring the evolution and potential of DUBTAC technology
Danfeng Wang1,2,3, Wenjian Min1,2,3, Binjian Jiang1,2,3
1State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory of Targetome and Innovative Drugs Medicines, China Pharmaceutical University, Nanjing 211198, China.
Deubiquitinase-targeting chimeras (DUBTAC) offer a novel therapeutic strategy by stabilizing target proteins like p53 and PTEN. This emerging technology shows promise for treating diseases by restoring protein function and targeting previously undruggable proteins.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Deubiquitinase-targeting chimeras (DUBTAC) are an emerging technology that precisely removes ubiquitin chains from target proteins.
- This process enhances target protein stability and restores or improves their physiological functions, offering therapeutic potential.
Purpose of the Study:
- To explore the design strategies of DUBTAC technology.
- To identify and recommend candidate proteins for DUBTAC-based drug development.
- To provide insights into drug design, structural optimization, and target selection for DUBTACs.
Main Methods:
- Review of DUBTAC technology principles and applications.
- Screening of potential protein targets amenable to DUBTAC-mediated stabilization.
- Analysis of design considerations for DUBTACs, including structural aspects.
Main Results:
- DUBTACs can stabilize key functional proteins, including tumor suppressors like p53, RB, and PTEN.
- The technology demonstrates potential for developing therapies against "undruggable" targets.
- Candidate proteins with therapeutic potential for DUBTAC targeting have been identified.
Conclusions:
- DUBTAC technology is a promising approach for drug discovery, particularly for challenging targets.
- Further research into DUBTAC design and target selection can unlock new therapeutic avenues.
- DUBTACs represent a significant advancement in stabilizing proteins to restore function and treat diseases.
Related Concept Videos
The Evidence for Evolution
Convergent Evolution
Self-Concept
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
Eukaryotic Evolution
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Concepts and Prototypes
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...

